Drug Shortage Report for GLYCOPYRROLATE INJECTION USP
Report ID | 177192 |
Drug Identification Number | 02473887 |
Brand name | GLYCOPYRROLATE INJECTION USP |
Common or Proper name | GLYCOPYRROLATE INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | GLYCOPYRROLATE |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1 vial 20 ml |
ATC code | A03AB |
ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-12-01 |
Estimated end date | 2023-02-06 |
Actual end date | 2023-02-01 |
Shortage status | Resolved |
Updated date | 2023-02-02 |
Company comments | Product is available at McKesson. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-02-02 | English | Compare |
v7 | 2023-02-01 | French | Compare |
v6 | 2023-02-01 | English | Compare |
v5 | 2023-02-01 | English | Compare |
v4 | 2022-12-06 | French | Compare |
v3 | 2022-12-06 | English | Compare |
v2 | 2022-12-06 | French | Compare |
v1 | 2022-12-06 | English | Compare |
Showing 1 to 8 of 8